Venrock Healthcare Capital Partners II, L.P. 13D and 13G filings for aTyr Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:07 pm Sale | 2022-12-31 | 13G | aTyr Pharma, Inc. ATYR | Venrock Healthcare Capital Partners II, L.P. | 1,171,436 4.000% | -393,564 (-25.15%) | Filing |
| 2022-02-14 4:17 pm Sale | 2021-12-31 | 13G | aTyr Pharma, Inc. ATYR | Venrock Healthcare Capital Partners II, L.P. | 1,565,000 5.600% | -250,000 (-13.77%) | Filing |
| 2021-09-27 5:14 pm Purchase | 2021-09-16 | 13G | aTyr Pharma, Inc. ATYR | Venrock Healthcare Capital Partners II, L.P. | 1,815,000 6.700% | 1,815,000 (New Position) | Filing |